Morgan Research forecasts that the GLP-1 market will exceed $100 billion by 2030, driven equally by diabetes and obesity usage
Additionally, GLP-1 promotes the growth and proliferation of pancreatic cells, inhibits glucagon secretion, and enhances glucose uptake in peripheral tissues, making it a crucial factor in maintaining blood glucose stability
Absorption After oral administration of a 100 mg dose to healthy subjects, sitagliptin was rapidly absorbed with peak plasma concentrations (median Tmax) occurring 1 to 4 hours postdose
However, patients with type 2 diabetes mellitus tend to lose less weight than those who are non-diabetic
While name-brand medications of semaglutide and tirzepatide are no longer on the shortage list, many telehealth providers continue to market and sell compounded GLP-1s , even after the FDA specifically banned this practice